Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC.JUNS · Entity 8326 | Director | June 02, 2025 | July 13, 2026 |
| MARIZYME, INC.MRZM · Entity 95786 | Director | June 07, 2022 | June 09, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
JUPITER NEUROSCIENCES, INC.
Report date June 02, 2025 · Filed July 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 82,875 |
Reported balance
After 2025-06-02 transaction · row 1
1 source rowRow 1 · 2025-06-02 · Exercise / conversion · Acquired 82,875 · Balance 82,875 F1: These restricted stock units convert into common stock on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2033-12-17 | Direct | 0 |
Reported balance
After 2025-06-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-06-02 · Exercise / conversion · Disposed 82,875 · Balance 0 F1: These restricted stock units convert into common stock on a one-for-one basis. F2: Represents restricted stock units which vested on the expiration of the lock-up period for the Issuer's initial public offering. |
Filing footnotes · ownership attribution and instrument terms
F1: These restricted stock units convert into common stock on a one-for-one basis.
F2: Represents restricted stock units which vested on the expiration of the lock-up period for the Issuer's initial public offering.
MARIZYME, INC.
Report date June 07, 2022 · Filed June 09, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.20 · Expires 2032-07-01 | Direct | 40,000 |
Reported balance
After 2022-06-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-06-07 · Grant · Acquired 40,000 · Balance 40,000 F1: Consists of an option to purchase 40,000 shares of common stock granted to the reporting person on June 7, 2022. The option vests over one year on a monthly basis in equal installments starting July 1, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of an option to purchase 40,000 shares of common stock granted to the reporting person on June 7, 2022. The option vests over one year on a monthly basis in equal installments starting July 1, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 02, 2026 Filed Jun 5, 2026 01:00 UTC | JUPITER NEUROSCIENCES, INC. JUNS · Entity 8326 | GrantStock Option · Derivative | 100,000 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0001493152-26-027363 · ownership.xml · derivative · entry 1 Kampf Julie B. · CIK 0001851594 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2036-06-02 F1 · derivative.exercise_date: The options were granted under the Issuer's 2025 Equity Incentive Plan. The options vest over three years commencing from September 2, 2026 in equal quarterly installments subject to continued service through each vesting date. Read SEC document |
| June 02, 2025 Filed Jul 13, 2026 20:00 UTC | JUPITER NEUROSCIENCES, INC. JUNS · Entity 8326 | Exercise / conversionRestricted Stock Units · Derivative | 82,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-033017 · ownership.xml · derivative · entry 2 Kampf Julie B. · CIK 0001851594 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 82,875 shares Expires 2033-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: These restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: Represents restricted stock units which vested on the expiration of the lock-up period for the Issuer's initial public offering. Read SEC document |
| June 02, 2025 Filed Jul 13, 2026 20:00 UTC | JUPITER NEUROSCIENCES, INC. JUNS · Entity 8326 | Exercise / conversionCommon Stock | 82,875 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-26-033017 · ownership.xml · nonDerivative · entry 1 Kampf Julie B. · CIK 0001851594 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 22:24 UTC | MARIZYME, INC. MRZM · Entity 95786 | GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001493152-22-016347 · ownership.xml · derivative · entry 1 Kampf Julie B. · CIK 0001851594 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-07-01 F1 · security: Consists of an option to purchase 40,000 shares of common stock granted to the reporting person on June 7, 2022. The option vests over one year on a monthly basis in equal installments starting July 1, 2022. F1 · derivative.exercise_date: Consists of an option to purchase 40,000 shares of common stock granted to the reporting person on June 7, 2022. The option vests over one year on a monthly basis in equal installments starting July 1, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.